Inventor

SAKSENA ANIL K

US56 patents

⚠️ This page may combine multiple inventors who share the name “SAKSENA ANIL K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SAKSENA ANIL K

SCHERING CORP

Peptides as NS3-serine protease inhibitors of hepatitis C virus

Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection

5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon

Compounds useful for inhibition of farnesyl protein transferase

Tetrahydrofuran antifungals

Inhibitors of hepatitis C virus NS3 protease

Compounds useful for inhibition of farnesyl protein transferase

Triazolo [4,5-d]-pyrimidines

Tetrahydrofuran antifungals

Tetrahydrofuran antifungals

Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof

Compounds as inhibitors of hepatitis C virus NS3 serine protease

Compounds as NS3-serine protease inhibitors of hepatitis C virus

Process for preparing intermediates for the synthesis of antifungal agents

Compounds as inhibitors of hepatitis C virus NS3 serine protease

Inhibitors of hepatitis C virus NS3 protease

Tetrahydrofuran antifungals

Tetrahydrofuran antifungals

Tetrahydrofuran antifungals

Process for preparing cyclopentyl purine derivatives

Topical Treatment of hyperproliferative skin diseases

Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection

Tricyclic N-cyanoimines useful as inhibitors of a farnesyl-protein transferase

Soluble azole antifungal salt

Nikkomycin analogs

Anti-fungal uracil compounds

Anti-fungal agents

Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection

Compounds useful for inhibition of farnesyl protein transferase

Orally active antiviral compounds

Processes for preparation of cyclopentyl purine derivatives

17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases

17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases

Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection

Tetrahydrofuran antifungal phosphate

Phenyl acetylenic acetals

Method for treating allergic reactions with Forskolin

Nikkomycin analogs

Anti-fungal agents

Oligosaccharide antibiotics and process for preparation thereof

Anti-fungal agents

2,4,4-tri- and 2,2,4,4-tetra substituted-1,3-dioxolane antifungal, antiallergy compounds

Hydroxy-substituted antifungals

Inhibitors of slow reacting substance of anaphylaxis

DENDREON CORP

Peptides as NS3-serine protease inhibitors of hepatitis C virus

Peptides as NS3-serine protease inhibitors of hepatitis C virus

Peptides as NS3-serine protease inhibitors of hepatitis C virus

SCHERING PLOUGH CORP

Method for treating allergic reactions with forskolin

SAKSENA ANIL K

Peptides as NS3-serine protease inhibitors of hepatitis C virus

BENNETT FRANK

Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease